Zura Bio (ZURA) Gains from Investment Securities (2022 - 2024)
Zura Bio's (ZURA) quarterly Gains from Investment Securities came in at $3.9 million in Q3 2024, up 3348.74% year-on-year from $112098.9 in Q4 2023, and up 403.39% quarter-over-quarter from $768000.0 in Q2 2024.
Zura Bio (ZURA) Gains from Investment Securities (2022 - 2024) Analysis & Trends
Zura Bio's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $3.9 million for Q3 2024.
- On a quarterly basis, Gains from Investment Securities rose 3348.74% year-over-year to $3.9 million in Q3 2024; TTM through Dec 2024 was $5.2 million, a 823.76% increase from a year earlier, with the FY2024 full-year figure at $5.2 million, up 823.76% from the prior year.
- Gains from Investment Securities climbed to $3.9 million in Q3 2024 per ZURA's latest filing, from $768000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $3.9 million in Q3 2024 and bottomed at -$960000.0 in Q4 2023.
- The 3-year median for Gains from Investment Securities is $336870.0 (2022), against an average of $531418.2.
- Across the five-year window, Gains from Investment Securities sank 649.41% in 2023 and jumped 3348.74% in 2024, its largest moves.
- Year by year, Gains from Investment Securities stood at -$128100.0 in 2022, then sank by 649.41% to -$960000.0 in 2023, then soared by 502.71% to $3.9 million in 2024.
- Per Business Quant, the three latest ZURA Gains from Investment Securities figures stand at $3.9 million (Q3 2024), $768000.0 (Q2 2024), and $606000.0 (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Zura Bio | 609.93 Mn | 609.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.87 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 768,000.00 |
| Mar 31, 2024 | 606,000.00 |
| Mar 31, 2024 | 606,000.00 |
| Dec 31, 2023 | -960,000.00 |
| Dec 31, 2023 | -960,000.00 |
| Sep 30, 2023 | -119,000.00 |
| Sep 30, 2023 | -119,000.00 |
| Jun 30, 2023 | 532,000.00 |
| Jun 30, 2023 | 532,000.00 |
| Mar 31, 2023 | -177,000.00 |
| Mar 31, 2023 | -177,000.00 |
| Dec 31, 2022 | -128,100.00 |
| Dec 31, 2022 | -128,100.00 |
| Sep 30, 2022 | -315,300.00 |
| Sep 30, 2022 | -315,300.00 |
| Jun 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | 1.44 Mn |